Multidisciplinary approaches to the health sciences are increasingly in demand – calling on multiple disciplines to tackle diseases from bench to bedside, from R&D through to patient care, often in multidisciplinary tumour boards or centres of excellence. Opportunities to publish this cross-cutting research are also on the increase, opening up new career horizons for investigators and other healthcare professionals.
Many angles, many disciplines at ILC 2021
ILC 2021 is all about beating liver disease together. We will tackle this challenge from multiple perspectives, drawing on multidisciplinary expertise, from all four corners of the globe. International Liver Congress™ 2021 taps right into this development, by offering you 34 categories of abstracts, from direct to cross-cutting relevance to the liver.
Register for ILC 2021 and bookmark these sessions, highlighted below, to make your programme align perfectly with your needs and interests.
A snapshot of multidisciplinary topics planned for ILC 2021
In preparation for ILC 2021, book these sessions in your calendar:
- Nurses and AHPs Forum, symposium: The art and science of collaborative working
26 June, 14:00–15:00 CET, interactive session
- The concluding, sixth session of the Postgraduate Course
Multidisciplinary outpatient approach to non-alcohol related fatty liver disease (NAFLD) and alcohol-related disease (ALD)
23 June, 16:45–17:45 CET, roundtable event
- Hepatic manifestations of IgG4-related disease, with a special focus on
IgG4-RD multidisciplinary team meeting with two clinical cases
24 June, 14:00–15:00 CET, interactive session drawing on a panel of experts, including hepatologist/gastroenterologist, reumatologist, HPB-radiologist, and –pathologist.
Explore 160+ related resources on EASL Campus
By logging into your free EASL Campus account, you can browse an array of 160+ resources drawing on multidisciplinary techniques and teams, from past EASL events.
- ILC 2020: A multidisciplinary approach to non-alcoholic fatty liver disease improves cardiovascular risk factors
- Online course, using a multidisciplinary approach: Management of the side effects of immune checkpoint inhibitors
- The début EASL–WHO webinar on COVID–19 and the liver
- NAFLD Summit 2019: NAFLD: a dynamic and multi-axis disease with many therapeutic targets: the challenge of collaboration
- HCC Summit 2019: Adverse events management in TKI-treatment and immunotherapy